Condition
Hemato-oncologic Patients clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Hemato-oncologic Patients clinical trials that are recruiting, at sites in 2 countries (most in France (1), China (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
G‑CSF plus IL‑11 for faster blood recovery after autologous stem cell transplant
This phase 2 trial will test whether adding IL‑11 to G‑CSF improves mobilization and speeds platelet and red blood cell recovery in adults having autologous stem cell transplant for multiple myeloma or lymphoma.
-
LOG-AFTER software to improve long-term monitoring of childhood cancer survivors
This project will test whether giving childhood cancer survivors access to the LOG-AFTER app (with optional GP linkage) helps them follow recommended long-term screenings.
Related topics
Quick answers
How many Hemato-oncologic Patients clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in France (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.